Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pennington

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|July 31, 2007
Targeting effector memory T-cells with Kv1.3 blockersHeike Wulff, Michael Pennington
Journal of Marital and Family Therapy|April 13, 2017
A Brief Report on the Ethical and Legal Guides For Technology Use in Marriage and Family TherapyMichael Pennington, Rikki Patton, Amber Ray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunityHeike Wulff, Hans-Günther Knaus, Michael Pennington, et al.
Bioconjugate Chemistry|October 15, 2014
FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissuesYumin Zheng, Shundong Ji, Andrzej Czerwinski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytesLina Hu, Michael Pennington, Qiong Jiang, et al.
Trends in Pharmacological Sciences|May 4, 2004
K+ channels as targets for specific immunomodulationK George Chandy, Heike Wulff, Christine Beeton, et al.
The Journal of Clinical Investigation|June 5, 2003
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MSHeike Wulff, Peter A Calabresi, Rameeza Allie, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|May 16, 2026
Translating Science into Practice Using University-State Government Partnerships: The EPIS ModelJanet A Welsh, Jochebed G Gayles, Sarah M Chilenski, et al.
Molecular Pharmaceutics|July 24, 2013
(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imagingShundong Ji, Andrzej Czerwinski, Yang Zhou, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 17, 2023
Treatment challenges of persistent ghost cell odontogenic carcinoma: a case report and literature reviewAli Al-Sammak, Othman Rezki, Michael Pennington, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|July 31, 2007
Targeting effector memory T-cells with Kv1.3 blockersHeike Wulff, Michael Pennington
Journal of Marital and Family Therapy|April 13, 2017
A Brief Report on the Ethical and Legal Guides For Technology Use in Marriage and Family TherapyMichael Pennington, Rikki Patton, Amber Ray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunityHeike Wulff, Hans-Günther Knaus, Michael Pennington, et al.
Bioconjugate Chemistry|October 15, 2014
FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissuesYumin Zheng, Shundong Ji, Andrzej Czerwinski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytesLina Hu, Michael Pennington, Qiong Jiang, et al.
Trends in Pharmacological Sciences|May 4, 2004
K+ channels as targets for specific immunomodulationK George Chandy, Heike Wulff, Christine Beeton, et al.
The Journal of Clinical Investigation|June 5, 2003
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MSHeike Wulff, Peter A Calabresi, Rameeza Allie, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|May 16, 2026
Translating Science into Practice Using University-State Government Partnerships: The EPIS ModelJanet A Welsh, Jochebed G Gayles, Sarah M Chilenski, et al.
Molecular Pharmaceutics|July 24, 2013
(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imagingShundong Ji, Andrzej Czerwinski, Yang Zhou, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 17, 2023
Treatment challenges of persistent ghost cell odontogenic carcinoma: a case report and literature reviewAli Al-Sammak, Othman Rezki, Michael Pennington, et al.
Pageof 2